FDA Import Refusal AEK-7476701-1/10002/1 — ABOTT HEALTHCARE
The FDA refused shipment AEK-7476701-1/10002/1 from ABOTT HEALTHCARE (India) on Aug 22, 2025. The refused product falls under Drugs and Biologics — FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Aug 22, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66TDY03 FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR)
- Charges
- 75